Xiyanping injection for COPD flare-ups
Part of Lungs & breathing clinical trials.
This study looks at whether Xiyanping injection, a Chinese medicine, helps people hospitalized for a COPD flare-up with a lung infection. It uses real-world data to see if the injection is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were discharged from the hospital with a diagnosis of COPD.
- You were in the hospital for COPD or a COPD flare-up along with a lower respiratory tract infection.
- If you received Xiyanping injection, you received it for at least 3 days.
- You have complete medical records available for the study.
- You did not use other similar Chinese medicine injections like Tanreqing or Reduning during treatment.
- You did not have viral pneumonia or another infection like a urinary tract infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a traditional Chinese medicine treatment can help people with a severe worsening of COPD. It is designed for those who have specific Chinese medicine patterns and are willing to try an additional therapy during their hospital stay.
This trial tests a traditional Chinese herbal formula called Xuanfei Jiangzhuo Decoction to see if it helps people with COPD who get sick with the flu. It may reduce the severity of flare-ups caused by influenza.
This study tests a new injection called XKH001 to see if it helps people with COPD (chronic lung disease) who have frequent flare-ups despite using regular inhaler medications. The goal is to reduce how often flare-ups happen and improve breathing.
This trial uses two simple blood tests (MxA and CRP) to help doctors decide whether you need antibiotics for a COPD flare-up. It aims to use medicines more wisely and avoid unnecessary side effects.
This trial tests a traditional Chinese herbal formula for treating sudden worsening of COPD symptoms (called acute exacerbations). It may help reduce inflammation and improve breathing during a flare-up for hospitalized patients.
This study tests whether using a blood test called CRP can help doctors decide when antibiotics are needed during a COPD flare-up. It may reduce unnecessary antibiotics while still treating infections when they’re likely.
Hear when a new Acute Exacerbation of Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.